MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway

被引:17
作者
Huang, Qingli [1 ]
Hou, Sen [2 ]
Zhu, Xiuqing [3 ]
Liu, Shouzhou [1 ]
机构
[1] Liaocheng Peoples Hosp, Dept Otorhinolaryngol Head & Neck Surg, 67 Dongchang West Rd, Liaocheng 252000, Shandong, Peoples R China
[2] Yanggu Peoples Hosp, Dept Otolaryngol, Liaocheng, Shandong, Peoples R China
[3] Chiping Peoples Hosp, Dept Otolaryngol, Liaocheng, Shandong, Peoples R China
关键词
miR-192; Nasopharyngeal carcinoma; RB1; PI3K; AKT pathway; CELL-PROLIFERATION; RETINOBLASTOMA PROTEIN; MIR-192; SUPPRESSES; TUMOR-SUPPRESSOR; CANCER CELLS; METASTASIS; INVASION; GROWTH; APOPTOSIS; PROGRESSION;
D O I
10.1186/s12957-020-1798-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The dysregulation of microRNAs (miRNAs) has been found in diseases and cancers, including microRNA-192 (miR-192). This study was designed to investigate the role of miR-192 in nasopharyngeal carcinoma (NPC) progression. Methods The expression levels of miR-192 and some genes were assessed by qRT-PCR and Western blot. The function of miR-192 was investigated through MTT, Transwell, and dual-luciferase reporter assays. Results The expression of miR-192 was increased in NPC tissues, and high miR-192 expression predicted poor prognosis in NPC patients. Functionally, upregulation of miR-192 promoted NPC cell migration, invasion, and growth. Furthermore, miR-192 activated EMT and PI3K/AKT pathway to regulate NPC progression. In addition, miR-192 directly targeted RB1 and suppressed its expression in NPC. Moreover, overexpression of RB1 weakened the promoted effect of miR-192 in NPC. Conclusion miR-192 promoted cell viability and metastasis in NPC through suppressing RB1 expression and activating PI3K/AKT pathway.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] microRNA-944 inhibits breast cancer cell proliferation and promotes cell apoptosis by reducing SPP1 through inactivating the PI3K/Akt pathway
    Zhang, Ying
    Li, Shan
    Cui, Xiangguo
    Wang, Yiliang
    APOPTOSIS, 2023, 28 (11-12) : 1546 - 1563
  • [32] CCDC86 promotes the aggressive behavior of nasopharyngeal carcinoma by positively regulating EGFR and activating the PI3K/Akt signaling
    Wang, Zhi
    Zhou, Tao
    Chen, Xubo
    Zhu, Xinhua
    Liao, Bing
    Liu, Jianguo
    Li, Siqi
    Tan, Ting
    Liu, Yuehui
    NEOPLASMA, 2023, 70 (06) : 761 - +
  • [33] Knockout of the placenta specific 8 gene radiosensitizes nasopharyngeal carcinoma cells by activating the PI3K/AKT/GSK3β pathway
    Yang, Rui
    Tao, Ze-Zhang
    Huang, Mao-Ling
    Zheng, Yong-Fa
    Dai, Meng-Yuan
    Zou, You
    Chen, Shi-Ming
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (02): : 455 - 464
  • [34] LncRNA NEAT1 regulates cervical carcinoma proliferation and invasion by targeting AKT/PI3K
    Guo, H. -M.
    Yang, S. -H.
    Zhao, S. -Z.
    Li, L.
    Yan, M. -T.
    Fan, M. -C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (13) : 4090 - 4097
  • [35] MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway
    Li, Lihua
    Zhu, Xiongjie
    Shou, Tao
    Yang, Libo
    Cheng, Xiaozhen
    Wang, Jinting
    Deng, Lian
    Zheng, Yanfang
    MOLECULAR MEDICINE REPORTS, 2018, 17 (03) : 4003 - 4010
  • [36] ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway
    Chen, Han
    Wang, Hengxiao
    Yu, Xiqiao
    Zhou, Shuping
    Zhang, Yueying
    Wang, Zhaopeng
    Huang, Shuhong
    Wang, Zhaoxia
    BMC CANCER, 2020, 20 (01)
  • [37] MicroRNA-145 inhibits growth of laryngeal squamous cell carcinoma by targeting the PI3K/Akt signaling pathway
    Ye, Dong
    Zhou, Chongchang
    Deng, Hongxia
    Lin, Lexi
    Zhou, Shuihong
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3801 - 3812
  • [38] MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway
    Fu, Xiao
    Wen, Hongqing
    Jing, Li
    Yang, Yujuan
    Wang, Wenjuan
    Liang, Xuan
    Nan, Kejun
    Yao, Yu
    Tian, Tao
    CANCER SCIENCE, 2017, 108 (04): : 620 - 631
  • [39] CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway
    Liu, Fu
    Zhi Shangli
    Hu, Zhili
    ONCOTARGETS AND THERAPY, 2018, 11 : 6209 - 6216
  • [40] MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway
    Zhang, Wei
    Zhang, Qiu
    Cui, Qianbo
    Xu, Yu
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2023, 42